Sirtuins and regulatory miRNAs as epigenetic determinants of empagliflozin-mediated recovery after acute myocardial infarction
Abstract Background Sodium-glucose cotransporter-2 (SGLT2) inhibitors, primarily used to treat type 2 diabetes, exhibit cardioprotective effects by improving myocardial energy metabolism, reducing oxidative stress, and modulating inflammation and fibrosis, which are critical in the context of acute...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2025-12-01
|
| Seri Bilgileri: | Cardiovascular Diabetology |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s12933-025-03013-y |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|